The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10447 malaria professionals are enjoying the free benefits of MalariaWorld today

Scientific Articles

Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites

November 23, 2010 - 09:54 -- Patrick Sampao
Author(s): 
Bo Jiang, Li Qin, Yanhua Du, Nanzheng Peng, Ling Chen, Zhiwei Chen, Xiaoping Chen
Reference: 
Vaccine, Volume 28, Issue 50, 23 November 2010, Pages 7915-7922

We demonstrated a novel vaccination strategy that uses a live transgenic protozoan parasite-based bivalent vaccine to immunize mice and confer significant levels of protection against VV-gag and malarial parasite challenges.

Medical Condition: 
Medical Treatment: 

Adult and child malaria mortality in India: a nationally representative mortality survey

November 23, 2010 - 09:27 -- Patrick Sampao
Author(s): 
The Lancet, Volume 376, Issue 9754, 20 November 2010-26 November 2010, Pages 1768-1774
Reference: 
Neeraj Dhingra., Prabhat Jha., Richard Peto., et al.

We aimed to estimate plausible ranges of malaria mortality in India, the most populous country where the disease remains common.

Person: 
Country: 
Medical Condition: 

Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal

November 23, 2010 - 08:11 -- Kabogo Ndegwa
Author(s): 
Oleksii A. Skorokhod, Luisa Caione, Tiziana Marrocco, Giorgia Migliardi, Valentina Barrera, Paolo Arese, Wanda Piacibello, and Evelin Schwarzer
Reference: 
Blood, 18 November 2010, Vol. 116, No. 20, pp. 4328-4337

Severe malaria anemia is characterized by inhibited/altered erythropoiesis and presence of hemozoin-(HZ)-laden bone-marrow macrophages.

Evaluation of Plasmodium vivax ELISA for the blood screen

November 23, 2010 - 07:42 -- Kabogo Ndegwa
Author(s): 
Myung-Hyun Nam, Jang Su Kim, Chi Hyun Cho, Eun Taek Han, Won Ja Lee, Hee Kyung Lee, Seong Soo A. An, Chae Seung Lim and Kap No Lee
Reference: 
Tropical Medicine & International Health, Volume 15, Issue 12, pages 1436–1441, December 2010

Plasmodium vivax malaria is the indigenous strain in the Republic of Korea (ROK). Plasmodium vivax can be transmitted through the transfusions of various blood components, which became a severe problem with the safety of blood transfusions and blood-related products in ROK.

Medical Condition: 

Laboratory malaria diagnostic capacity in health facilities in five administrative zones of Oromia Regional State, Ethiopia

November 23, 2010 - 07:22 -- Kabogo Ndegwa
Author(s): 
Bereket Hailegiorgis, Samuel Girma, Richard Reithinger, et al.
Reference: 
Tropical Medicine & International Health, Volume 15, Issue 12, pages 1449–1457, December 2010

This is the first published report on malaria diagnostic capacity in Ethiopia.

Country: 
Medical Condition: 
Medical Treatment: 

Informed decision-making before changing to RDT: a comparison of microscopy, rapid diagnostic test and molecular techniques for the diagnosis and identification of malaria parasites in Kassala, eastern Sudan

November 23, 2010 - 07:15 -- Kabogo Ndegwa
Author(s): 
Mamoun M. M. Osman, Bakri Y. M. Nour, Mohamed F. Sedig, Laura De Bes, Adil M. Babikir, Ahmed A. Mohamedani and Petra F. Mens
Reference: 
Tropical Medicine & International Health, Volume 15, Issue 12, pages 1442–1448, December 2010

PCR has proven to be one of the most specific and sensitive diagnostic methods, particularly for malaria cases with low parasitaemia.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Dose‐Dependent Risk of Neutropenia after 7‐Day Courses of Artesunate Monotherapy in Cambodian Patients with Acute Plasmodium falciparum Malaria

November 23, 2010 - 06:59 -- Kabogo Ndegwa
Author(s): 
Delia Bethell, Youry Se, Mark M. Fukuda, et al.
Reference: 
Clinical Infectious Diseases 15 December 2010, Vol. 51, No. 12:

Artesunate remains a crucial drug for the treatment of malaria, and determining optimal dosing regimens is vital to overcome emerging resistant parasite strains along the Thai‐Cambodian border.

Country: 
Medical Treatment: 

Open Access | Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

November 19, 2010 - 12:41 -- Kabogo Ndegwa
Author(s): 
Pedro Aide, John J. Aponte, Pedro L. Alonso, et al.
Reference: 
PLoS ONE 5(11): e13838

The RTS,S/AS02D malaria vaccine administered to young infants has a good safety profile and remains efficacious over 14 months.

Person: 
Country: 
Medical Condition: 
Medical Treatment: 

Elevated Levels of Soluble TNF Receptors 1 and 2 Correlate with Plasmodium falciparum Parasitemia in Pregnant Women: Potential Markers for Malaria-Associated Inflammation

November 19, 2010 - 12:35 -- Kabogo Ndegwa
Author(s): 
Audrey Davidson Thévenon, James A. Zhou, Rosette Megnekou, Simon Ako, Rose G. F. Leke, and Diane Wallace Taylor
Reference: 
The Journal of Immunology December 1, 2010 vol. 185 no. 11 7115-7122

Plasmodium falciparum-infected erythrocytes (IEs) sequester in the intervillous space (IVS) of the placenta causing placental malaria (PM), a condition that increases a woman’s chances of having a low-birth-weight baby.

Pages

Subscribe to Scientific Articles